THEODORE VYE: Open Payments
NPI 1609894278 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,060 in 78 payments from 21 companies in 2025. Trend: 2023 $2,259 · 2024 $2,166 · 2025 $2,060
Food & beverage: $2,060
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $464 |
| PFIZER INC. | 16 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $164 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $151 |
| ABBVIE INC. | 5 | $122 |
| Abbott Laboratories | 5 | $118 |
| Dexcom, Inc. | 1 | $87 |
| Novo Nordisk Inc | 4 | $79 |
| Corcept Therapeutics | 3 | $65 |
| Axsome Therapeutics, Inc. | 1 | $62 |
Products named: FARXIGA, ELIQUIS, CAPLYTA, Kerendia, NURTEC ODT, AIRSUPRA, FREESTYLE LIBRE 3, UBRELVY.
Industry payments across WA — which companies pay providers there.
